封面
市场调查报告书
商品编码
1994800

全球媒介传播疾病监测人工智慧(AI)市场报告(2026年)

Vector-Borne Disease Surveillance Artificial Intelligence (AI) Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,用于病原体传播疾病监测的人工智慧(AI)市场发展迅速。预计该市场将从2025年的16亿美元成长到2026年的19.2亿美元,复合年增长率(CAGR)为19.9%。过去几年成长要素包括病原体传播疾病发病率的上升、公共卫生监测项目的扩展、地理空间健康数据的增长、全球健康监测计划的实施以及数位化疾病报告的普及。

预计未来几年,用于媒介传播疾病监测的人工智慧(AI)市场将大幅成长,到2030年将达到40.1亿美元,复合年增长率(CAGR)为20.2%。预测期内的成长要素包括对人工智慧驱动的疫情预测的需求、气候变迁导致的媒介传播扩散、智慧感测器监测网路、跨境健康数据平台以及预测性公共卫生规划。预测期内的关键趋势包括人工智慧驱动的疫情预测模型、与气候变迁相关的媒介风险地图绘製、自动化物种识别系统、即时流行病学仪錶板以及整合的多源监测平台。

预计未来几年,媒介传播疾病发生率的上升将推动人工智慧(AI)在媒介传播疾病监测领域的市场扩张。媒介传播疾病是由蚊子、蜱虫和跳蚤等媒介传播的病原体引起的疾病,正日益成为全球公共卫生领域的严峻挑战。气候变迁、都市化、人口迁移以及媒介栖息地的扩张是导致这些疾病增加的主要原因,使得疾病的地理覆盖范围更广,发病率更高。人工智慧驱动的媒介传播疾病监测将有助于应对这些挑战,其实现即时数据整合、早期疫情检测、预测分析以及更有效地分配公共卫生资源。例如,根据泛美卫生组织(PAHO)的数据(由英国卫生与安全局于2024年6月发布),2024年1月至6月期间,美洲共记录了9,386,082例登革热病例(4,630,669例确诊病例和4,529例死亡病例),比2023年同期增长了123.29%。因此,媒介传播疾病发生率的上升正在推动媒介传播疾病监测人工智慧市场的成长。

在媒介传播疾病监测人工智慧市场中,主要企业正致力于即时媒介预测技术的进步,例如人工智慧驱动的智慧监测系统,以期透过提高疫情预测的准确性、增强精准干预能力和提升公共卫生决策水平来获得竞争优势。这些系统将人工智慧与物联网感测器和分析功能结合,用于监测蚊虫族群、检测蚊虫种类和环境状况,并触发针对性干预警报,从而实现比传统方法更准确、更及时的公共卫生反应。例如,2025年7月,印度公共部门城市发展机构-安得拉邦市政管理和城市发展局(Andhra Pradesh Municipal Administration and Urban Development Authority)部署了智慧蚊虫监测系统(SMoSS)。 SMoSS提供了一个人工智慧驱动的即时监测平台,用于追踪高风险都市区的蚊虫族群。该系统整合了智慧感测器、诱捕器、无人机和物联网基础设施,用于收集连续的现场数据并产生热力图,以识别蚊虫滋生地和疫情爆发热点。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球媒介传播疾病监测人工智慧(AI)市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单:主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章:全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧(AI)和自主人工智慧
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施、互联生态系统
    • 永续性、气候技术、循环经济
  • 主要趋势
    • 人工智慧驱动的感染疾病爆发预测模型
    • 气候相关病媒风险图
    • 自动物种辨识系统
    • 即时流行病学仪錶盘
    • 整合多源监测平台

第五章 终端用户产业市场分析

  • 政府公共卫生机构
  • 医疗保健提供者
  • 研究机构
  • 流行病学中心
  • 非营利性卫生组织

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及 COVID-19 疫情对市场的影响。

第七章:全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球媒介传播疾病监测人工智慧(AI)市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球媒介传播疾病监测人工智慧(AI)市场规模、对比及成长率分析
  • 全球媒介传播疾病监测人工智慧(AI)市场表现:规模与成长,2020-2025年
  • 全球媒介传播疾病监测人工智慧(AI)市场预测:规模与成长,2025-2030年,2035年预测

第八章:全球市场总规模(TAM)

第九章 市场细分

  • 按组件
  • 软体、硬体和服务
  • 部署模式
  • 基于云端,本地部署
  • 透过使用
  • 疟疾监测、登革热监测、兹卡病毒监测、莱姆病追踪及其他用途
  • 最终用户
  • 政府机构、医疗保健提供者、研究机构和其他最终用户
  • 按类型细分:软体
  • 预测分析软体、资料管理软体、视觉化软体、报表和仪表板软体、地理空间地图绘製软体
  • 按类型细分:硬体
  • 感测器和侦测设备、穿戴式监控设备、监视录影机、资料储存设备、网路设备
  • 按类型细分:服务
  • 咨询服务、实施服务、维护和支援服务、培训和教育服务、整合服务

第十章 区域与国别分析

  • 全球媒介传播疾病监测人工智慧(AI)市场:按地区划分,实际值和预测值,2020-2025年、2025-2030年预测值、2035年预测值
  • 全球媒介传播疾病监测人工智慧(AI)市场:按国家划分,实际值和预测值,2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章:中国市场

第十三章:印度市场

第十四章:日本市场

第十五章:澳洲市场

第十六章:印尼市场

第十七章:韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章:德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章:东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第三十章:加拿大市场

第31章:南美市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第三十五章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 媒介传播疾病监测人工智慧(AI)市场:竞争格局与市场份额,2024年
  • 媒介传播疾病监测人工智慧(AI)市场:公司估值矩阵
  • 媒介传播疾病监测人工智慧(AI)市场:公司概况
    • Amazon Web Services Inc.
    • Microsoft Corporation
    • International Business Machines Corporation
    • Siemens Healthineers AG
    • Plexus Health Surveillance

第37章 其他大型企业和创新企业

  • SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

第38章:全球市场竞争基准分析与仪錶板

第39章:预计进入市场的Start-Ups

第四十章 重大併购

第41章 具有高市场潜力的国家、细分市场与策略

  • 2030年媒介传播疾病监测人工智慧(AI)市场:提供新机会的国家
  • 2030年媒介传播疾病监测人工智慧(AI)市场:提供新机会的细分领域
  • 2030年媒介传播疾病监测人工智慧(AI)市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第42章附录

简介目录
Product Code: IT4MVBDS01_G26Q1

Vector borne disease surveillance artificial intelligence (AI) involves the application of AI technologies to monitor, predict, and control diseases transmitted by vectors such as mosquitoes, ticks, and other insects. It analyzes environmental, climate, and health data to identify trends and forecast outbreaks with greater precision. This system supports faster responses and more effective public health interventions through real-time analysis of complex datasets.

The primary components of vector-borne disease surveillance artificial intelligence (AI) include software, hardware, and services. Software consists of AI-driven platforms that gather, process, and forecast the transmission patterns of vector-borne diseases using real-time data inputs. These platforms can be implemented through cloud-based environments or on-premises deployments. They are applied in malaria surveillance, dengue monitoring, Zika virus tracking, Lyme disease surveillance, and other applications, and are used by end users such as government agencies, healthcare providers, research institutes, and other end users.

Tariffs are affecting the vector borne disease surveillance AI market mainly through increased costs of imported sensors, field detection devices, and surveillance hardware. Higher duties on monitoring equipment and networking devices are raising deployment costs for public health agencies and research programs. Regions dependent on imported sensing and diagnostic hardware are seeing slower rollout of integrated surveillance systems. Hardware intensive field monitoring segments are more exposed than pure software analytics platforms. Cloud based AI tools are less directly impacted by tariff changes. At the same time, tariffs are encouraging local manufacturing of sensing and monitoring equipment. This supports regional health technology suppliers and system integrators.

The vector-borne disease surveillance artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides vector-borne disease surveillance artificial intelligence (AI) market statistics, including vector-borne disease surveillance artificial intelligence (AI) industry global market size, regional shares, competitors with a vector-borne disease surveillance artificial intelligence (AI) market share, detailed vector-borne disease surveillance artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the vector-borne disease surveillance artificial intelligence (AI) industry. This vector-borne disease surveillance artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vector-borne disease surveillance artificial intelligence (AI) market size has grown rapidly in recent years. It will grow from $1.6 billion in 2025 to $1.92 billion in 2026 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increase in vector borne disease outbreaks, expansion of public health surveillance programs, growth in geospatial health data, global health monitoring initiatives, adoption of digital disease reporting.

The vector-borne disease surveillance artificial intelligence (AI) market size is expected to see exponential growth in the next few years. It will grow to $4.01 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to AI based epidemic forecasting demand, climate change driven vector spread, smart sensor surveillance networks, cross border health data platforms, predictive public health planning. Major trends in the forecast period include AI driven outbreak prediction models, climate linked vector risk mapping, automated species identification systems, real time epidemiological dashboards, integrated multi source surveillance platforms.

The rising incidence of vector-borne diseases is expected to support the expansion of the vector-borne disease surveillance artificial intelligence (AI) market in the coming years. Vector-borne diseases are illnesses caused by pathogens transmitted through vectors such as mosquitoes, ticks, and fleas, and they represent a growing global public health challenge. The increasing occurrence of these diseases is driven by climate change, urbanization, population movement, and expanding vector habitats, which have resulted in wider geographic spread and more frequent outbreaks. AI-powered vector-borne disease surveillance helps address these challenges by enabling real-time data integration, early outbreak identification, predictive analytics, and improved allocation of public health resources. For example, according to the Pan American Health Organization (PAHO), as reported by the UK Health Security Agency in June 2024, the Region of the Americas recorded 9,386,082 dengue cases, including 4,630,669 confirmed cases and 4,529 deaths between January and June 2024, representing a 103.29% increase compared to the same period in 2023. Therefore, the rising incidence of vector-borne diseases is advancing the growth of the vector-borne disease surveillance AI market.

Leading companies operating in the vector-borne disease surveillance AI market are focusing on technological advancements in real-time vector prediction, such as AI-powered smart surveillance systems, to gain competitive advantage through improved outbreak forecasting, targeted intervention capabilities, and enhanced public health decision-making. These systems integrate artificial intelligence with Internet-of-Things sensors and analytics to monitor mosquito populations, detect species and environmental conditions, and trigger alerts for targeted interventions, enabling more precise and timely public health responses compared to traditional methods. For instance, in July 2025, the Andhra Pradesh Municipal Administration and Urban Development Department, a public sector urban development entity in India, introduced the Smart Mosquito Surveillance System (SMoSS). The Smart Mosquito Surveillance System (SMoSS) provides an AI-driven, real-time monitoring platform to track mosquito populations in high-risk urban areas. It integrates smart sensors, traps, drones, and IoT infrastructure to collect continuous field data and generate heat maps identifying mosquito breeding and infestation hotspots.

In June 2025, bioMerieux, a France-based provider of in vitro diagnostic technologies, acquired the assets of Day Zero Diagnostics for an undisclosed amount. This acquisition aims to enhance bioMerieux's next-generation sequencing and machine learning capabilities, enabling faster identification of infectious pathogens and antibiotic resistance profiles for real-time disease surveillance. Day Zero Diagnostics is a US-based company specializing in machine learning-powered genome sequencing solutions for rapid pathogen detection.

Major companies operating in the vector-borne disease surveillance artificial intelligence (AI) market are Amazon Web Services Inc., Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers AG, Plexus Health Surveillance, SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

North America was the largest region in the vector-borne disease surveillance Artificial Intelligence (AI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vector-borne disease surveillance artificial intelligence (AI) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vector-borne disease surveillance artificial intelligence (AI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vector borne disease surveillance artificial intelligence (AI) market consists of revenues earned by entities by providing services such as real-time vector monitoring, outbreak prediction, data analysis and modeling, risk assessment, reporting and visualization, early warning alerts, decision support, public health intervention planning, predictive analytics, and surveillance system integration. The vector borne disease surveillance artificial intelligence (AI) market also includes sales of AI-powered species identification tools, smart surveillance & monitoring platforms, risk forecasting systems, community reporting apps, and pathogen detection platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses vector-borne disease surveillance artificial intelligence (AI) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vector-borne disease surveillance artificial intelligence (AI) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vector-borne disease surveillance artificial intelligence (AI) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Deployment Mode: Cloud-Based; On-Premises
  • 3) By Application: Malaria Surveillance; Dengue Surveillance; Zika Virus Monitoring; Lyme Disease Tracking; Other Applications
  • 4) By End-User: Government Agencies; Healthcare Providers; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Software: Predictive Analytics Software; Data Management Software; Visualization Software; Reporting and Dashboard Software; Geospatial Mapping Software
  • 2) By Hardware: Sensors and Detection Devices; Wearable Monitoring Devices; Surveillance Cameras; Data Storage Devices; Networking Devices
  • 3) By Services: Consulting Services; Implementation Services; Maintenance and Support Services; Training and Education Services; Integration Services
  • Companies Mentioned: Amazon Web Services Inc.; Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers AG; Plexus Health Surveillance; SAS Institute Inc.; Palantir Technologies Inc.; Informatica LLC; Vector Surveillance System; Environmental Systems Research Institute Inc.; Cloudera Inc.; HealthMap; GIDEON Informatics; Metabiota Inc.; EcoHealth Alliance Inc.; BlueDot Inc.; BioSense Technologies; Artificial Intelligence in Medical Epidemiology; Vector Technology & Management Consulting Group; Aira Matrix
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 AI Driven Outbreak Prediction Models
    • 4.2.2 Climate Linked Vector Risk Mapping
    • 4.2.3 Automated Species Identification Systems
    • 4.2.4 Real Time Epidemiological Dashboards
    • 4.2.5 Integrated Multi Source Surveillance Platforms

5. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Analysis Of End Use Industries

  • 5.1 Government Public Health Agencies
  • 5.2 Healthcare Providers
  • 5.3 Research Institutes
  • 5.4 Epidemiology Centers
  • 5.5 Nonprofit Health Organizations

6. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Segmentation

  • 9.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premises
  • 9.3. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Malaria Surveillance, Dengue Surveillance, Zika Virus Monitoring, Lyme Disease Tracking, Other Applications
  • 9.4. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Government Agencies, Healthcare Providers, Research Institutes, Other End Users
  • 9.5. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Predictive Analytics Software, Data Management Software, Visualization Software, Reporting and Dashboard Software, Geospatial Mapping Software
  • 9.6. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sensors and Detection Devices, Wearable Monitoring Devices, Surveillance Cameras, Data Storage Devices, Networking Devices
  • 9.7. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation Services, Maintenance and Support Services, Training and Education Services, Integration Services

10. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Regional And Country Analysis

  • 10.1. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 11.1. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 12.1. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 13.1. India Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 14.1. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 15.1. Australia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 16.1. Indonesia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 17.1. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 18.1. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 19.1. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 20.1. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 21.1. UK Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 22.1. Germany Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 23.1. France Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 24.1. Italy Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 25.1. Spain Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 26.1. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 27.1. Russia Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 28.1. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 29.1. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 30.1. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 31.1. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 32.1. Brazil Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 33.1. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

  • 34.1. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Regulatory and Investment Landscape

36. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Landscape And Company Profiles

  • 36.1. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Company Profiles
    • 36.3.1. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Plexus Health Surveillance Overview, Products and Services, Strategy and Financial Analysis

37. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Other Major And Innovative Companies

  • SAS Institute Inc., Palantir Technologies Inc., Informatica LLC, Vector Surveillance System, Environmental Systems Research Institute Inc., Cloudera Inc., HealthMap, GIDEON Informatics, Metabiota Inc., EcoHealth Alliance Inc., BlueDot Inc., BioSense Technologies, Artificial Intelligence in Medical Epidemiology, Vector Technology & Management Consulting Group, Aira Matrix

38. Global Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market

41. Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market High Potential Countries, Segments and Strategies

  • 41.1 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Vector-Borne Disease Surveillance Artificial Intelligence (AI) Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer